A betegség lefolyásának elorejelzése gyulladásos bélbetegségekben

Translated title of the contribution: Prediction of the disease course in infl ammatory bowel diseases

Lajos Sándor Kiss, P. Lakatos

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis (UC) are heterogeneous and variable over time. During follow up, intestinal strictures or perforation may eventually develop at most patients with CD, and significant number of patients will undergo surgery. Much emphasis was laid in recent years on the determination of important predictive factors. Since early introduction of immunomodulators and/or biologicals might be justified in patients at risk for disease progression, so it is important to identify these patients as soon as possible. This review article summarizes the available literature on important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors and hopefully will assist clinicians in the everyday practice decision making when choosing the treatment strategy in their patients with inflammatory bowel diseases.

Original languageHungarian
Pages (from-to)293-301
Number of pages9
JournalOrvosi Hetilap
Volume151
Issue number8
DOIs
Publication statusPublished - Feb 1 2010

Fingerprint

Crohn Disease
Immunologic Factors
Ulcerative Colitis
Inflammatory Bowel Diseases
Disease Progression
Decision Making
Pathologic Constriction
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A betegség lefolyásának elorejelzése gyulladásos bélbetegségekben. / Kiss, Lajos Sándor; Lakatos, P.

In: Orvosi Hetilap, Vol. 151, No. 8, 01.02.2010, p. 293-301.

Research output: Contribution to journalArticle

@article{c94f69e7173a4dd19fcf56e39e6275d4,
title = "A betegs{\'e}g lefoly{\'a}s{\'a}nak elorejelz{\'e}se gyullad{\'a}sos b{\'e}lbetegs{\'e}gekben",
abstract = "Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis (UC) are heterogeneous and variable over time. During follow up, intestinal strictures or perforation may eventually develop at most patients with CD, and significant number of patients will undergo surgery. Much emphasis was laid in recent years on the determination of important predictive factors. Since early introduction of immunomodulators and/or biologicals might be justified in patients at risk for disease progression, so it is important to identify these patients as soon as possible. This review article summarizes the available literature on important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors and hopefully will assist clinicians in the everyday practice decision making when choosing the treatment strategy in their patients with inflammatory bowel diseases.",
keywords = "Clinical, Crohn's disease, Disease course, Genetics, Infl ammatory bowel disease, Predictive markers, Serology, Ulcerative colitis",
author = "Kiss, {Lajos S{\'a}ndor} and P. Lakatos",
year = "2010",
month = "2",
day = "1",
doi = "10.1556/OH.2010.28813",
language = "Hungarian",
volume = "151",
pages = "293--301",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "8",

}

TY - JOUR

T1 - A betegség lefolyásának elorejelzése gyulladásos bélbetegségekben

AU - Kiss, Lajos Sándor

AU - Lakatos, P.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis (UC) are heterogeneous and variable over time. During follow up, intestinal strictures or perforation may eventually develop at most patients with CD, and significant number of patients will undergo surgery. Much emphasis was laid in recent years on the determination of important predictive factors. Since early introduction of immunomodulators and/or biologicals might be justified in patients at risk for disease progression, so it is important to identify these patients as soon as possible. This review article summarizes the available literature on important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors and hopefully will assist clinicians in the everyday practice decision making when choosing the treatment strategy in their patients with inflammatory bowel diseases.

AB - Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis (UC) are heterogeneous and variable over time. During follow up, intestinal strictures or perforation may eventually develop at most patients with CD, and significant number of patients will undergo surgery. Much emphasis was laid in recent years on the determination of important predictive factors. Since early introduction of immunomodulators and/or biologicals might be justified in patients at risk for disease progression, so it is important to identify these patients as soon as possible. This review article summarizes the available literature on important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors and hopefully will assist clinicians in the everyday practice decision making when choosing the treatment strategy in their patients with inflammatory bowel diseases.

KW - Clinical

KW - Crohn's disease

KW - Disease course

KW - Genetics

KW - Infl ammatory bowel disease

KW - Predictive markers

KW - Serology

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=77249137317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249137317&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28813

DO - 10.1556/OH.2010.28813

M3 - Article

C2 - 20154000

AN - SCOPUS:77249137317

VL - 151

SP - 293

EP - 301

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 8

ER -